Breast Inflammatory Carcinoma — Research

Breast Inflammatory Carcinoma — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed3 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Records (count)	Exact query	Computed	Source
All time	… → 2026-09-12	728	`("Inflammatory Breast Neoplasms"[mh] OR "Breast Cancer, Inflammatory"[mh] OR "Breast Carcinoma, Inflammatory"[mh] OR "Inflammatory Breast Cancer IBC"[mh])`	2026-09-12	pubmed
Last 5 years	2021-01-01 → 2026-12-31	227	`("Inflammatory Breast Neoplasms"[mh] OR "Breast Cancer, Inflammatory"[mh] OR "Breast Carcinoma, Inflammatory"[mh] OR "Inflammatory Breast Cancer IBC"[mh]) AND (2021/01/01:2026/12/31[dp])`	2026-09-12	pubmed
Last 12 months	2025-09-12 → 2026-09-12	31	`("Inflammatory Breast Neoplasms"[mh] OR "Breast Cancer, Inflammatory"[mh] OR "Breast Carcinoma, Inflammatory"[mh] OR "Inflammatory Breast Cancer IBC"[mh]) AND (2025/09/12:2026/09/12[dp])`	2026-09-12	pubmed

Data updated 18 days agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (1)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–1 of 1 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

MMP2 and MMP9 serum levels are associated with favorable outcome in patients with inflammatory breast cancer treated with bevacizumab-based neoadjuvant chemotherapy in the BEVERLY-2 study.
· Oncotarget · 2016 · PMID 26921265 · validated civic_curation pubmed